Display options
Cite
Morceau F, Diederich M. Breakthrough in tracking tumor erythropoietin receptor expression. Chin Clin Oncol. 2012;1(2):24doi: 10.3978/j.issn.2304-3865.2012.12.05.
Morceau, F., & Diederich, M. (2012). Breakthrough in tracking tumor erythropoietin receptor expression. Chinese clinical oncology, 1(2), 24. https://doi.org/10.3978/j.issn.2304-3865.2012.12.05
Morceau, Franck, and Diederich, Marc. "Breakthrough in tracking tumor erythropoietin receptor expression." Chinese clinical oncology vol. 1,2 (2012): 24. doi: https://doi.org/10.3978/j.issn.2304-3865.2012.12.05
Morceau F, Diederich M. Breakthrough in tracking tumor erythropoietin receptor expression. Chin Clin Oncol. 2012 Dec;1(2):24. doi: 10.3978/j.issn.2304-3865.2012.12.05. PMID: 25841402.
Copy Download .nbib Format: NLM
Share it on

Chin Clin Oncol. 2012 Dec;1(2):24. doi: 10.3978/j.issn.2304-3865.2012.12.05.

Breakthrough in tracking tumor erythropoietin receptor expression.

Chinese clinical oncology

Franck Morceau, Marc Diederich

Affiliations

  1. Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9, rue Edward Steichen, 2540 Luxembourg, Luxembourg.
  2. College of Pharmacy, Seoul National University, Seoul 151-742, South Korea. [email protected].

PMID: 25841402 DOI: 10.3978/j.issn.2304-3865.2012.12.05

[No abstract available.]

Publication Types